[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ctnnb1-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"CTNNB1 Gene",4,3,[8,16,23,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06600321","A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma",[12],"Phase 1","RECRUITING","2026-08-26T02:17:32.059863Z","2026-05-05T02:43:29.538970Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06811116","Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:37.277498Z","2026-05-05T02:43:26.673894Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05919264","FOG-001 in Locally Advanced or Metastatic Solid Tumors",[20],"2026-08-26T02:19:03.581490Z","2026-07-24T01:27:14.928476Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT03610906","Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:59.895916Z","2026-06-16T05:54:07.967963Z"]